Published : Jul-2017
No. of Pages : 39
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Hemophilia: Executive Summary 5
2.1 Related Reports 6
2.2 Upcoming Reports 6
3 Epidemiology 7
3.1 Disease Background 7
3.2 Risk Factors and Comorbidities 8
3.3 Global and Historical Trends 8
3.4 Forecast Methodology 10
3.4.1 Sources 10
3.4.2 Forecast Assumptions and Methods 13
3.4.3 Diagnosed Prevalent Cases 14
3.4.4 Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B by Severity 15
3.4.5 Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B by Inhibitors 18
3.5 Epidemiological Forecast for Hemophilia A (2016-2026) 19
3.5.1 Diagnosed Prevalent Cases of Hemophilia A 19
3.5.2 Age-Specific Diagnosed Prevalent Cases of Hemophilia A 19
3.5.3 Sex-Specific Diagnosed Prevalent Cases of Hemophilia A 20
3.5.4 Diagnosed Prevalent Cases of Hemophilia A by Severity 21
3.5.5 Diagnosed Prevalent Cases of Hemophilia A with Inhibitors 22
3.6 Epidemiological Forecast for Hemophilia B (2016-2026) 23
3.6.1 Diagnosed Prevalent Cases of Hemophilia B 23
3.6.2 Age-Specific Diagnosed Prevalent Cases of Hemophilia B 23
3.6.3 Sex -Specific Diagnosed Prevalent Cases of Hemophilia B 24
3.6.4 Diagnosed Prevalent Cases of Hemophilia B by Severity 25
3.6.5 Diagnosed Prevalent Cases of Hemophilia B with Inhibitors 27
3.7 Epidemiological Forecast for Hemophilia A and Hemophilia B (2016-2026) 27
3.7.1 Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B 27
3.7.2 Age-Specific Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B 28
3.7.3 Sex -Specific Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B 29
3.7.4 Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B by Severity 30
3.7.5 Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B with Inhibitors 31
3.8 Discussion 32
3.8.1 Epidemiological Forecast Insight 32
3.8.2 Limitations of the Analysis 33
3.8.3 Strengths of the Analysis 33
4 Appendix 35
4.1 Bibliography 35
4.2 About the Authors 37
4.2.1 Epidemiologist 37
4.2.2 Reviewers 37
4.2.3 Global Director of Therapy Analysis and Epidemiology 38
4.2.4 Global Head and EVP of Healthcare Operations and Strategy 38
4.3 About GlobalData 39
4.4 Contact Us 39
4.5 Disclaimer 39
1.1 List of Tables
Table 1: Relationship of Bleeding Severity with Clotting Factor Level. 7
Table 2: Comorbidities for Hemophilia 8
Table 3: 7MM, Diagnosed Prevalent Cases of Hemophilia A, Both Sexes, All Ages, N, Selected Years 2016-2026. 19
Table 4: 7MM, Diagnosed Prevalent Cases of Hemophilia B, Both Sexes, All Ages, N, Selected Years 2016-2026. 23
Table 5: 7MM, Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B, Both Sexes, All Ages, N, Selected Years 2016-2026. 28
1.2 List of Figures
Figure 1: 7MM, Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B, Both Sexes, All Ages, 2016 and 2026 6
Figure 2: 7MM, Age-Standardized Diagnosed Prevalence of Hemophilia A (Cases per 100,000 Population), All Ages, 2016 9
Figure 3: 7MM, Age-Standardized Diagnosed Prevalence of Hemophilia B (Cases per 100,000 Population), All Ages, 2016 10
Figure 4: 7MM, Sources Used, Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B 11
Figure 5: 7MM, Sources Used, Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B by Severity 12
Figure 6: 7MM, Sources Used, Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B with Inhibitors 13
Figure 7: 7MM, Age-Specific Diagnosed Prevalent Cases of Hemophilia A, Both Sexes, All Ages, N, 2016 20
Figure 8: 7MM, Sex-Specific Diagnosed Prevalent Cases of Hemophilia A, Both Sexes, All Ages, N, 2016 21
Figure 9: 7MM, Diagnosed Prevalent Cases of Hemophilia A by Severity, Both Sexes, All Ages, N, 2016 22
Figure 10: 7MM, Diagnosed Prevalent Cases of Hemophilia A with Inhibitors, Both Sexes, All Ages, N, 2016 22
Figure 11: 7MM, Age-Specific Diagnosed Prevalent Cases of Hemophilia B, Both Sexes, All Ages, 2016 24
Figure 12: 7MM, Sex-Specific Diagnosed Prevalent Cases of Hemophilia B, Both Sexes, All Ages, N, 2016 25
Figure 13: 7MM, Diagnosed Prevalent Cases of Hemophilia B by Severity, Both Sexes, All Ages, N, 2016 26
Figure 14: 7MM, Diagnosed Prevalent Cases of Hemophilia B with Inhibitors, Both Sexes, All Ages, N, 2016 27
Figure 15: 7MM, Age-Specific Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B, Both Sexes, All Ages, N, 2016 29
Figure 16: 7MM, Sex-Specific Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B, All Ages, N, 2016 30
Figure 17: 7MM, Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B by Severity, Both Sexes, All Ages, N, 2016 31
Figure 18: 7MM, Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B with Inhibitors, Both Sexes, All Ages, N, 2016 32
